VT-1161 protects mice against oropharyngeal candidiasis caused by fluconazole-susceptible and -resistant Candida albicans

The Investigational Fungal Cyp51 Inhibitor VT-1129 Demonstrates PotentIn VitroActivity against Cryptococcus neoformans and Cryptococcus gattii

(2016) Shawn R. Lockhart et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Fungal CYP51 Inhibitors VT-1161 and VT-1129 Exhibit Strong In Vitro Activity against Candida glabrata and C. krusei Isolates Clinically Resistant to Azole and Echinocandin Antifungal Compounds

(2016) W. A. Schell et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Evaluation of VT-1161 for Treatment of Coccidioidomycosis in Murine Infection Models

(2015) Lisa F. Shubitz et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

VT-1161 Protects Immunosuppressed Mice from Rhizopus arrhizus var. arrhizus Infection

(2015) Teclegiorgis Gebremariam et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Efficacy of the Clinical Agent VT-1161 against Fluconazole-Sensitive and -Resistant Candida albicans in a Murine Model of Vaginal Candidiasis

(2015) E. P. Garvey et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

VT-1161 Dosed Once Daily or Once Weekly Exhibits Potent Efficacy in Treatment of Dermatophytosis in a Guinea Pig Model

(2015) E. P. Garvey et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

The Clinical Candidate VT-1161 Is a Highly Potent Inhibitor of Candida albicans CYP51 but Fails To Bind the Human Enzyme

(2014) A. G. S. Warrilow et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

CX3CR1 Is Dispensable for Control of Mucosal Candida albicans Infections in Mice and Humans

(2014) Timothy J. Break et al.   INFECTION AND IMMUNITY

Oral-resident natural Th17 cells and γδ T cells control opportunisticCandida albicansinfections

(2014) Heather R. Conti et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Vulvovaginalcandidiasis: species distribution, fluconazole resistance and drug efflux pump gene overexpression

(2014) Jie-Yu Zhang et al.   MYCOSES

Mendelian Genetics of Human Susceptibility to Fungal Infection

(2014) M. S. Lionakis et al.   Cold Spring Harbor Perspectives in Medicine

Interleukin-17-Induced Protein Lipocalin 2 Is Dispensable for Immunity to Oral Candidiasis

(2013) Maria Carolina Ferreira et al.   INFECTION AND IMMUNITY

The adaptor protein CIKS/ACT1 is necessary for collagen-induced arthritis, and it contributes to the production of collagen-specific antibody

(2010) Prapaporn Pisitkun et al.   ARTHRITIS AND RHEUMATISM